Global Leader in Bacteriophage Technology
LyseNTech is licensed for bacteriophages by the Bacteriophage Bank of Korea (supported by funds from Ministry of Science and ICT of Korea). Our core technologies include the development of antibacterials using bacteriophages and phage-derived endolysins and development of target specific oncolytic bacteriophages.
Established July 23rd, 2019 | CEO: Heejoon Myung
Location: Room 215, Natural Sciences Building, Hankuk University of Foreign Studies, Yong-In, Gyeonggi-Do 17035, Korea